Get the Stockscreener App
87.75
1.59%
1.4326
Zimmer Biomet Holdings Inc stock is traded at $87.75, with a volume of 1.12M.
It is up +1.59% in the last 24 hours and down -12.18% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$86.32
Open:
$86.91
24h Volume:
1.12M
Relative Volume:
0.52
Market Cap:
$17.16B
Revenue:
$8.23B
Net Income/Loss:
$705.10M
P/E Ratio:
24.74
EPS:
3.5467
Net Cash Flow:
$1.12B
1W Performance:
-1.56%
1M Performance:
-12.18%
6M Performance:
-9.57%
1Y Performance:
-20.56%
1-Day Range:
$86.15
$87.94
1-Week Range:
$85.83
$90.76
52-Week Range:
$84.59
$114.44
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
87.69 | 16.89B | 8.23B | 705.10M | 1.12B | 3.5467 |
ABT
Abbott Laboratories
|
105.42 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
326.85 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.70 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.50 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.30 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-20-26 | Initiated | William Blair | Mkt Perform |
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Jan-06-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jul-15-25 | Upgrade | Roth Capital | Neutral → Buy |
| Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now? - TradingView
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
BTIG downgrades Zimmer Biomet Holdings (ZBH) - MSN
Zimmer Biomet: Down On Its Knees, Shares Look Appealing (NYSE:ZBH) - Seeking Alpha
BTIG downgrades Zimmer Biomet, sees limited upside amid growth challenges - Investing.com Canada
This Box Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
Zimmer Biomet (NYSE:ZBH) Given Neutral Rating at BTIG Research - MarketBeat
BTIG Downgrades Zimmer Biomet Holdings(ZBH.US) to Hold Rating - Moomoo
BTIG Downgrades Zimmer Biomet Holdings (ZBH) Rating to Neutral | ZBH Stock News - GuruFocus
Zimmer Biomet stock rating cut to neutral by BTIG on growth concerns - Investing.com
Zimmer Biomet (NYSE:ZBH) Reflects Activity In S&P 500 Fund Segment - Kalkine Media
Zimmer Biomet Holdings, Inc. $ZBH Shares Bought by Northside Capital Management LLC - MarketBeat
Gains Recap: Will Zimmer Biomet Holdings Inc benefit from AI trends2026 Stock Rankings & Precise Swing Trade Alerts - baoquankhu1.vn
Wilsey Asset Management Inc. Invests $32.44 Million in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Surgical Equipment & ConsumablesDiversified Stocks Q4 In Review: Zimmer Biomet (NYSE:ZBH) Vs Peers - Yahoo Finance
Pre-market 19 Mar 2026: ZBH.SW Zimmer Biomet (SIX) CHF67.50 -4.26%: analyst grade - Meyka
Canaccord Genuity Maintains Zimmer Biomet Holdings (ZBH) Hold Recommendation - MSN
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
ZIMMER BIOMET HOLDINGS INCRo Khanna Congressional Trade on Feb. 05, 2026 - Quiver Quantitative
JPMorgan Chase & Co. Reduces Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Stock (ISIN: US98956P1021) Faces Institutional Selling Pressure Amid Steady D - AD HOC NEWS
Moore Capital Management LP Trims Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Delta Global Management LP Makes New Investment in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Ameriprise Financial Inc. Has $373.24 Million Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Knee Replacement Market Set to Witness Significant Growth from - openPR.com
ZBH.SW down 4.26% pre-market on SIX: Zimmer Biomet faces near-term support test - Meyka
Zimmer Biomet declares $0.24 dividend - MSN
How Is Zimmer Biomet Holdings’ Stock Performance Compared to Other Medical Devices Stocks? - Yahoo Finance
Winkler Lori, SVP of Zimmer Biomet, sells $250k in stock - Investing.com Australia
Winkler Lori, SVP of Zimmer Biomet, sells $250k in stock By Investing.com - Investing.com South Africa
Zimmer Biomet Holdings Insider Sold Shares Worth $250,849, According to a Recent SEC Filing - marketscreener.com
Zimmer Biomet (NYSE:ZBH) SVP Sells $250,849.00 in Stock - MarketBeat
Zimmer Biomet (NYSE: ZBH) SVP sells 2,650 shares in open market - Stock Titan
Cash per share of Zimmer Biomet Holdings, Inc. – VIE:ZBH - TradingView
Is Zimmer Biomet’s Q4 Beat And 2026 Guidance Altering The Investment Case For ZBH? - simplywall.st
Zimmer Biomet tops Q4 expectations but strikes measured tone on 2026 guidance - MSN
Zimmer Biomet (ZBH) Valuation Check After Earnings Beat And Updated Growth Outlook - Yahoo Finance
Zimmer Biomet (ZBH) Valuation Check As AAOS 2026 Robotics And Smart Implant Showcase Nears - Sahm
Dodge & Cox Boosts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
A Look At Zimmer Biomet (ZBH) Valuation After Mixed Recent Share Price Returns - simplywall.st
Zimmer Biomet outlines 2026 revenue growth of 1%–3% amid US sales force overhaul and innovation cycle - MSN
Zimmer Biomet Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Zimmer Biomet Holdings, Inc. Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
Korea Investment CORP Sells 79,643 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. $ZBH Shares Acquired by First Trust Advisors LP - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Why has Zimmer (ZBH) dropped 2% following its most recent earnings announcement? - Bitget
[144] ZIMMER BIOMET HOLDINGS, INC. SEC Filing - Stock Titan
Why Is Zimmer (ZBH) Down 2% Since Last Earnings Report? - Yahoo Finance
Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Swiss National Bank - MarketBeat
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):